Page last updated: 2024-11-11

sophoricoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sophoricoside: from fruit of Sophora japonica; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
SophoragenusA plant genus of the family FABACEAE.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID5321398
CHEMBL ID486626
CHEBI ID188772
SCHEMBL ID1156059
MeSH IDM0331803

Synonyms (42)

Synonym
sophoricoside
NCGC00142616-01
bdbm50242276
AKOS000272974
CHEMBL486626 ,
FT-0654659
CHEBI:188772
5,7-dihydroxy-3-[4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one
152-95-4
STK918164
4-(5,7-dihydroxy-4-oxo-4h-chromen-3-yl)phenyl beta-d-glucopyranoside
3-{4-[(2s,4s,5s,3r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)(2h-3,4,5,6-tetrahydr opyran-2-yloxy)]phenyl}-5,7-dihydroxychromen-4-one
unii-j0407l5mgm
4h-1-benzopyran-4-one, 3-(4-(beta-d-glucopyranosyloxy)phenyl)-5,7-dihydroxy- sophoricoside
genistein, 4'-beta-d-glucopyranoside
5',7'-dihydroxy-4'-glucosyloxyisoflavone
genistein sophoricoside [mi]
genistein sophoricoside
j0407l5mgm ,
SCHEMBL1156059
5,7-dihydroxy-3-(4-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)phenyl)-4h-chromen-4-one
W-201364
genistein-4'-o-glucoside
Q-100181
4h-1-benzopyran-4-one, 3-(4-(.beta.-d-glucopyranosyloxy)phenyl)-5,7-dihydroxy- sophoricoside
genistein, 4'-.beta.-d-glucopyranoside
100455-45-6
AC-7997
mfcd01075138
HY-N0423
CS-0008948
5,7-dihydroxy-3-(4-((2s,3r,4s,5s,6r)-
sophoricoside,(s)
tetrahydro-2h-pyran-2-yloxy)phenyl)-4h-chromen-4-one
3,4,5-trihydroxy-6-(hydroxymethyl)
AS-12103
Q7563141
(2s)-n-boc-5-methylpyrrolidine-2-carboxylicacid
DTXSID601017840
mfcd01084295
XG161814
genistein-4?-o-glucoside

Research Excerpts

Overview

Sophoricoside (SOPH) is an isoflavone glycoside isolated from Fructus Sophorae. It has the effects on reproductive system.

ExcerptReferenceRelevance
"Sophoricoside (SOPH) is an isoflavone glycoside isolated from Fructus Sophorae, and it has the effects on reproductive system. "( A simple and sensitive UHPLC-Q-TOF-MS/MS method for sophoricoside metabolism study in vitro and in vivo.
Liang, C; Sun, Y; Yin, J; Zhang, L; Zhang, X, 2017
)
2.15
"Sophoricoside is an isoflavone glycoside (Genistein-4'-O-β-d-glucopyranoside) isolated from S."( Hepatoprotective Effects of Sophoricoside against Fructose-Induced Liver Injury via Regulating Lipid Metabolism, Oxidation, and Inflammation in Mice.
Li, W; Lu, Y, 2018
)
1.5
"Sophoricoside (SOPH) is an isoflavone isolated from Sophora japonica (Leguminosae). "( Sophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-κB signaling in B cells.
Han, SB; Hong, JT; Kang, JS; Kim, HS; Kim, JS; Kim, Y; Kim, YJ; Lee, HK; Park, YS; Yuk, DY, 2013
)
3.28
"Sophoricoside (SOPH) is an isoflavone glycoside isolated from the fruits of Sophora japonica. "( Sophoricoside fails the embryo implantation by compromising the uterine endometrial receptivity at implantation "window" of pregnant mice.
Liu, Y; Qu, C; Sun, Q; Wu, L; Yang, Z; Zhang, J; Zhou, J, 2014
)
3.29

Effects

ExcerptReferenceRelevance
"Sophoricoside has been identified as a selective inhibitor of cyclooxygenase (COX)-2 activity with an IC50 value of 3.3 microM."( Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity.
Chung, EY; Kim, BH; Kim, MK; Kim, Y; Lee, SH; Min, BK; Min, KR, 2003
)
1.3

Actions

ExcerptReferenceRelevance
"Sophoricoside can also increase the activity of osteoprotegerin promoter and is more effective than genistein."( [Effects of sophoricoside and genistein on biological characteristics of osteoblasts].
Chen, WZ; Du, N; Xu, Y, 2009
)
1.45

Treatment

ExcerptReferenceRelevance
"Treatment with sophoricoside at concentrations of 1-10 μM inhibited lipid accumulation in HepG2 cells in a dose-dependent manner."( Modulation of lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes by sophoricoside.
Chen, X; Guo, P; Jin, L; Luan, H; Wang, R; Wang, S; Wu, C; Zhang, X, 2013
)
0.95

Pharmacokinetics

The developed method was successfully applied to the pharmacokinetic study of sophoricoside after intravenous administration of 2. The mean elimination half-life (t1/2) of sophricoside and genistein were 59.

ExcerptReferenceRelevance
" The mean elimination half-life (t1/2) of sophoricoside and genistein were 59."( Pharmacokinetics and excretion study of sophoricoside and its metabolite in rats by liquid chromatography tandem mass spectrometry.
Jia, P; Sheng, N; Yuan, L; Zhang, L; Zhang, X; Zhang, Z; Zhi, X, 2014
)
0.93
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
isoflavonoidAny 1-benzopyran with an aryl substituent at position 3. The term was originally restricted to natural products, but is now also used to describe semi-synthetic and fully synthetic compounds.
acrovestoneA polyphenol that is isolated from Acronychia pedunculata and exhibits moderate antioxidant and antityrosinase activities.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency44.66840.003245.467312,589.2998AID2517
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency35.48130.177814.390939.8107AID2147
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.66840.011212.4002100.0000AID1030
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))IC50 (µMol)100.00000.00000.503510.0000AID366284; AID366285; AID366286
Interleukin-5Mus musculus (house mouse)IC50 (µMol)8.30001.40001.40001.4000AID1195063; AID1500909; AID487255; AID491866; AID689110; AID725081; AID744644
Substance-P receptorCavia porcellus (domestic guinea pig)IC50 (µMol)100.00000.00002.751810.0000AID366285
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)IC50 (µMol)10.60000.00030.81978.4900AID744644
Substance-K receptorCavia porcellus (domestic guinea pig)IC50 (µMol)100.00000.01500.01500.0150AID366285
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID689111Inhibition of IL-5 in mouse Y16 cells at 30 uM after 48 hrs by WST1 assay2012Bioorganic & medicinal chemistry, Oct-01, Volume: 20, Issue:19
Novel interleukin-5 inhibitors based on hydroxyethylaminomethyl-4H-chromen-4-one scaffold.
AID491866Inhibition of interleukin-5 in mouse Y16 cells2010Bioorganic & medicinal chemistry, Jul-01, Volume: 18, Issue:13
Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity.
AID744642Inhibition interleukin-5 in mouse Y16 cells at 30 uM after 48 hrs by WST-1 assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Design and synthesis of novel chromenone derivatives as interleukin-5 inhibitors.
AID671764Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1500909Inhibition of mouse IL-5-induced cell proliferation in mouse Y16 cells after 48 hrs by WST-1 assay relative to control2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of novel 3-(hydroxyalkoxy)-2-alkylchromen-4-one analogs as interleukin-5 inhibitors.
AID487232Antiinflammatory activity against mouse Y16 cells assessed as inhibition of IL5 production2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5.
AID689110Inhibition of IL-5 in mouse Y16 cells after 48 hrs by WST1 assay2012Bioorganic & medicinal chemistry, Oct-01, Volume: 20, Issue:19
Novel interleukin-5 inhibitors based on hydroxyethylaminomethyl-4H-chromen-4-one scaffold.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID725083Inhibition of IL-5 in mouse pro-B Y16 cells at 30 uM after 48 hrs by WST1 assay2013European journal of medicinal chemistry, Jan, Volume: 59Identification of novel chromenone derivatives as interleukin-5 inhibitors.
AID487255Inhibition of IL5-mediated proliferation of mouse Y16 cells by WST1 assay2010Bioorganic & medicinal chemistry, Jun-15, Volume: 18, Issue:12
The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5.
AID491865Inhibition of interleukin-5 in mouse Y16 cells at 50 uM2010Bioorganic & medicinal chemistry, Jul-01, Volume: 18, Issue:13
Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity.
AID487254Inhibition of IL5-mediated proliferation of mouse Y16 cells at 50 uM by WST1 assay2010Bioorganic & medicinal chemistry, Jun-15, Volume: 18, Issue:12
The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5.
AID487234Antiinflammatory activity against mouse Y16 cells assessed as inhibition of IL5 production at 50 uM2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5.
AID366284Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID1570318Inhibition of IL-5 receptor in mouse pro-B Y16 cells assessed as decrease in mIL-5 dependent cell proliferation at 50 uM after 48 hrs in presence of 3 units/ml mIL-5 by WST-1 assay relative to control2019European journal of medicinal chemistry, Nov-01, Volume: 181Discovery of benzimidazole analogs as a novel interleukin-5 inhibitors.
AID744644Inhibition interleukin-5 in mouse Y16 cells after 48 hrs by WST-1 assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Design and synthesis of novel chromenone derivatives as interleukin-5 inhibitors.
AID1195062Inhibition of mouse IL5-mediated mouse Y16 cell proliferation at 30 uM after 48 hrs by WST1 assay2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Exploration of benzamidochromenone derivatives with conformational restrictor as interleukin-5 inhibitors.
AID671762Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1195063Inhibition of mouse IL5-mediated mouse Y16 cell proliferation after 48 hrs by WST1 assay2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Exploration of benzamidochromenone derivatives with conformational restrictor as interleukin-5 inhibitors.
AID366285Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID366286Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID1500908Inhibition of mouse IL-5-induced cell proliferation in mouse Y16 cells at 50 uM after 48 hrs by WST-1 assay relative to control2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of novel 3-(hydroxyalkoxy)-2-alkylchromen-4-one analogs as interleukin-5 inhibitors.
AID725081Inhibition of IL-5 in mouse pro-B Y16 cells after 48 hrs by WST1 assay2013European journal of medicinal chemistry, Jan, Volume: 59Identification of novel chromenone derivatives as interleukin-5 inhibitors.
AID671761Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1570317Inhibition of IL-5 receptor in mouse pro-B Y16 cells assessed as decrease in mIL-5 dependent cell proliferation after 48 hrs in presence of 3 units/ml mIL-5 by WST-1 assay2019European journal of medicinal chemistry, Nov-01, Volume: 181Discovery of benzimidazole analogs as a novel interleukin-5 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.33)18.7374
1990's1 (2.33)18.2507
2000's10 (23.26)29.6817
2010's23 (53.49)24.3611
2020's8 (18.60)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.60 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]